Physician profile
Todd Ryan Grunander
NPI 1336396340
$16,817.99
in general payments reported to CMS, 2019-2025
8 companies · $15K in 2025
The $15K reported for 2025 was more than what 79% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $141 · 2022: $1,466 · 2023: $36.67 · 2024: $131 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $1,493 · Food and Beverage: $818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,900.00 |
| Travel and Lodging | $1,493.12 |
| Food and Beverage | $818.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $14,938.72 | 2025 | Journey II, Real Intelligence, Journey II Xr |
| Zimmer Biomet Holdings, INC. | $1,567.65 | 2021-2023 | Persona |
| Depuy Synthes Sales INC. | $131.31 | 2024 | Attune, Velys |
| Pacira Pharmaceuticals Incorporated | $62.21 | 2021-2025 | Exparel |
| Teleflex LLC | $47.97 | 2021 | |
| Ethicon US, LLC | $28.27 | 2025 | Vistaseal, Surgiflo Hemostatic Matrix, Stratafix |
| Total Joint Orthopedics, INC. | $26.72 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $15.14 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Grunander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.